CSE1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.67409999973778E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.93289999853519E-08 |
Normal-vs-Stage2 |
2.29919999999995E-05 |
Normal-vs-Stage3 |
1.12870000013032E-07 |
Normal-vs-Stage4 |
4.600900E-03 |
Stage1-vs-Stage2 |
7.256600E-01 |
Stage1-vs-Stage3 |
7.673400E-01 |
Stage1-vs-Stage4 |
8.441800E-02 |
Stage2-vs-Stage3 |
6.587800E-01 |
Stage2-vs-Stage4 |
2.359800E-01 |
Stage3-vs-Stage4 |
8.902300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.30930000017149E-07 |
Normal-vs-AfricanAmerican |
1.51919998803152E-09 |
Normal-vs-Asian |
9.855600E-02 |
Caucasian-vs-AfricanAmerican |
4.664800E-03 |
Caucasian-vs-Asian |
8.634200E-01 |
AfricanAmerican-vs-Asian |
1.941410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.42879999737767E-08 |
Normal-vs-Female |
3.28599999999124E-06 |
Male-vs-Female |
1.634580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.475800E-03 |
Normal-vs-Age(41-60Yrs) |
3.22959999854433E-08 |
Normal-vs-Age(61-80Yrs) |
2.37059999963485E-07 |
Normal-vs-Age(81-100Yrs) |
1.44150000003229E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.713800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.262800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.051600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.172800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.188600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.299600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.960300E-04 |
Normal-vs-Grade 2 |
1.80530000004619E-06 |
Normal-vs-Grade 3 |
1.18820000505337E-08 |
Normal-vs-Grade 4 |
1.143650E-03 |
Grade 1-vs-Grade 2 |
9.612000E-01 |
Grade 1-vs-Grade 3 |
4.112200E-01 |
Grade 1-vs-Grade 4 |
9.042000E-01 |
Grade 2-vs-Grade 3 |
2.891700E-02 |
Grade 2-vs-Grade 4 |
8.247400E-01 |
Grade 3-vs-Grade 4 |
1.992950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.97150000009239E-07 |
Normal-vs-ccB subtype |
8.203000000373E-07 |
ccA subtype-vs-ccB subtype |
8.791600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.232000000437E-07 |
Normal-vs-N1 |
2.977600E-01 |
N0-vs-N1 |
6.927600E-02 |
|
|